Fig. 2From: 18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse gliomaReceiver operating characteristic (ROC) curves of the prediction models. ROC curve of the clinical (a), radiomics (b), and fusion (c) predictive models in both the primary and validation cohortsBack to article page